Skip to NavigationSkip to content

News

0
Jazz Pharmaceuticals has announced that its dopamine and norepinephrine reuptake inhibitor (DNRI) Sunosi (solriamfetol) has been approved by the...
0
This week was a bad week for clinical trials. While the FDA put Roche and AbbVie’s multiple myeloma trial on hold after a number of patient deaths...
0
FDA officials have called on the federal agency to halt the approval of new narcotic painkillers.
0
The Tate network of art galleries has said it will no longer accept gifts from the notorious Sackler family, the billionaire controllers of...

Features

Alison Hollands, Vice President, Respiratory, UK Pharmaceuticals at GlaxoSmithKline, addresses the importance of implementing the latest...